The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ASCO 2019 | Squamous cell lung cancer: gene targets

Name: Squamous cell lung cancer: gene targets
Uploaded: 2019-06-03T00:00:00Z
Duration: 55 s
Description: Here, Paul Paik of the Memorial Sloan Kettering Cancer Center, New York, NY discusses the development of treatments for squamous cell lung cancer and the importance of identifying new targets such as NFA202. This interview was recorded at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Paul Paik • 3 Jun 2019

ASCO 2019

Lung Cancer

Here, Paul Paik of the Memorial Sloan Kettering Cancer Center, New York, NY discusses the development of treatments for squamous cell lung cancer and the importance of identifying new targets such as NFA202. This interview was recorded at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.